Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ASO Visual Abstract: Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survival in Colorectal Cancer.
Qin Y, Miyake T, Muramoto K, Maekawa T, Nishina Y, Wang Y, Shimizu T, Tani M. Qin Y, et al. Among authors: muramoto k. Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16750-3. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39738896 No abstract available.
A Case of Rapid Emergence of Small-cell Carcinoma due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsy.
Jodai Y, Saruwatari K, Muramoto K, Imamura K, Sakata S, Yoshida C, Miyasato Y, Honda Y, Tomita Y, Ichiyasu H, Sakagami T. Jodai Y, et al. Among authors: muramoto k. Intern Med. 2024 Dec 26. doi: 10.2169/internalmedicine.4566-24. Online ahead of print. Intern Med. 2024. PMID: 39721692 Free article.
Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survival in Colorectal Cancer.
Qin Y, Miyake T, Muramoto K, Maekawa T, Nishina Y, Wang Y, Shimizu T, Tani M. Qin Y, et al. Among authors: muramoto k. Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16593-y. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39623187
A case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resection.
Tokuoka K, Muramoto K, Sakanaka K, Yoshihara K, Yamamoto S, Imai Y, Iwatani K, Tashiro K, Murakami M, Harada T, Hayashimoto T, Umemori M, Kimura T, Shimomura T, Urabe F. Tokuoka K, et al. Among authors: muramoto k. Int Cancer Conf J. 2024 Aug 31;13(4):510-514. doi: 10.1007/s13691-024-00720-3. eCollection 2024 Oct. Int Cancer Conf J. 2024. PMID: 39398921
327 results